The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's Disease
Open accessAbstract
In situ end labeling combined with YOYO staining was used to mark apoptotic DNA fragmentation and chromatin condensation respectively in human postmortem brain sections. Increased numbers of apoptotic neuronal nuclei were identified in the Parkinson's disease (PD) nigra compared with age-matched controls. Caspase 3 and Bax showed increased immunoreactivity in melanized neurons of the PD nigra compared with controls. Importantly, GAPDH nuclear accumulation was also observed in the PD nigra, suggesting apoptotic rather than necrotic cell death. Interestingly, both Lewy bodies and the intranuclear Marinesco's bodies were GAPDH immunoreactive in the PD brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Current protocols in molecular biology
Sargent, T. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90147-9 · Cited by 7,205
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Movement of Bax from the Cytosol to Mitochondria during Apoptosis
Wolter, K. G., Hsu, Y.-T., Smith, C. L., Nechushtan, A., Xi, X.-G., & Youle, R. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.5.1281 · Cited by 1,806
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Caspase structure, proteolytic substrates, and function during apoptotic cell death
Nicholson, D. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400598 · Cited by 1,543
Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of Apoptosis
Marzo, I., Brenner, C., Zamzami, N., Jürgensmeier, J. M., Susin, S. A., Vieira, H. L. A., Prévost, M.-C., Xie, Z., Matsuyama, S., Reed, J. C., et al. (1998) · Science · doi:10.1126/science.281.5385.2027 · Cited by 1,168
Oberhammer, F., Wilson, J. W., Dive, C., Morris, I. D., Hickman, J. A., Wakeling, A. E., Walker, P. R., & Sikorska, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06042.x · Cited by 1,131
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., Prigent, A., Ruberg, M., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 1,037
Cohen, G. M., Sun, X. M., Snowden, R. T., Dinsdale, D., & Skilleter, D. N. (1992) · Biochemical Journal · doi:10.1042/bj2860331 · Cited by 672
Susin, S. A., Zamzami, N., Castedo, M., Daugas, E., Wang, H.-G., Geley, S., Fassy, F., Reed, J. C., & Kroemer, G. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.25 · Cited by 615
Peitsch, M. C., Polzar, B., Stephan, H., Crompton, T., MacDonald, H. R., Mannherz, H. G., & Tschopp, J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05666.x · Cited by 546
Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12706-3 · Cited by 545
Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain
Busser, J., Geldmacher, D. S., & Herrup, K. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02801.1998 · Cited by 543
Tatton, N. A., & Kish, S. J. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00545-3 · Cited by 468
Self-citationHistochemical detection of apoptosis in Parkinson's disease
Mochizuki, H., Goto, K., Mori, H., & Mizuno, Y. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00336-z · Cited by 452
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 431
Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation
Sahara, S., Aoto, M., Eguchi, Y., Imamoto, N., Yoneda, Y., & Tsujimoto, Y. (1999) · Nature · doi:10.1038/43678 · Cited by 429
Anderson, A., Su, J., & Cotman, C. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-05-01710.1996 · Cited by 389
Bax-Dependent Caspase-3 Activation Is a Key Determinant in p53-Induced Apoptosis in Neurons
Cregan, S. P., MacLaurin, J. G., Craig, C. G., Robertson, G. S., Nicholson, D. W., Park, D. S., & Slack, R. S. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-07860.1999 · Cited by 385
Cassarino, D. S., & Bennett, J. P. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00046-0 · Cited by 379
Dypbukt, J. M., Ankarcrona, M., Burkitt, M., Sjöholm, A., Ström, K., Orrenius, S., & Nicotera, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43849-5 · Cited by 362
Dragunow, M., Faull, R. L. M., Lawlor, P., Beilharz, E. J., Singleton, K., Walker, E. B., & Mee, E. (1995) · NeuroReport · doi:10.1097/00001756-199505090-00026 · Cited by 342
Shimizu, S., Ide, T., Yanagida, T., & Tsujimoto, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12321 · Cited by 338
Bax Involvement in p53-Mediated Neuronal Cell Death
Xiang, H., Kinoshita, Y., Knudson, C. M., Korsmeyer, S. J., Schwartzkroin, P. A., & Morrison, R. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-04-01363.1998 · Cited by 330
Sawa, A., Khan, A. A., Hester, L. D., & Snyder, S. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11669 · Cited by 317
Schapira, A. H. V. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00164-9 · Cited by 310
Aloyz, R. S., Bamji, S. X., Pozniak, C. D., Toma, J. G., Atwal, J., Kaplan, D. R., & Miller, F. D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.6.1691 · Cited by 302
Tompkins, M. M., Basgall, E. J., ZAMRINI, E. Y., & Hill, W. D. (1997) · Europe PMC (PubMed Central) · Cited by 291
Basañez, G., Nechushtan, A., Drozhinin, O., Chanturiya, A., Choe, E., Tutt, S., Wood, K. A., Hsu, Y.-T., Zimmerberg, J., & Youle, R. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5492 · Cited by 270
Sirover, M. A. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970801)66:2<133::aid-jcb1>3.0.co;2-r · Cited by 243
Wadia, J. S., Chalmers-Redman, R. M. E., Ju, W. J. H., Carlile, G. W., Phillips, J. L., Fraser, A. D., & Tatton, W. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-03-00932.1998 · Cited by 230
MIGHELI, A., CAVALLA, P., MARINO, S., & SCHIFFER, D. (1994) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199411000-00008 · Cited by 205
Bär, W., Kratzer, A., Mächler, M., & Schmid, W. (1988) · Forensic Science International · doi:10.1016/0379-0738(88)90118-1 · Cited by 205
A fluorescent double‐labeling method to detect and confirm apoptotic nuclei in parkinson's disease
Tatton, N. A., Maclean‐Fraser, A., Tatton, W. G., Perl, D. P., & Warren, C. O. (1998) · Annals of Neurology · doi:10.1002/ana.410440721 · Cited by 202
Self-citationJanota, I. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.1.95-f · Cited by 194
Didenko, V. V., & Hornsby, P. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.5.1369 · Cited by 189
Ishitani, R., & Chuang, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9937 · Cited by 186
Role of mitochondria in the etiology and pathogenesis of Parkinson's disease
Mizuno, Y., Ikebe, S.-I., Hattori, N., Nakagawa-Hattori, Y., Mochizuki, H., Tanaka, M., & Ozawa, T. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00038-6 · Cited by 172
Distinction of apoptotic and necrotic cell death by in situ labelling of fragmented DNA
Kressel, M., & Groscurth, P. (1994) · Cell & Tissue Research · doi:10.1007/bf00331373 · Cited by 167
Ishitani, R., Tanaka, M., Sunaga, K., Katsube, N. C., & Chuang, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.4.701 · Cited by 156
Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging.
Anglade, P., Vyas, S., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 155
Chromatin condensation during apoptosis requires ATP
Kass, G. E. N., Eriksson, J., Weis, M., Orrenius, S., & Chow, S. C. (1996) · Biochemical Journal · doi:10.1042/bj3180749 · Cited by 150
On the question of apoptosis in the parkinsonian substantia nigra
Kösel, S., Egensperger, R., Eitzen, U. V., Mehraein, P., & Graeber, M. B. (1997) · Acta Neuropathologica · doi:10.1007/s004010050590 · Cited by 145
Lucassen, P., Chung, W., Kamphorst, W., & Swaab, D. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00007 · Cited by 142
General pathology of neurons and neuroglia
Duchen, L. W. (1992) · Medical Entomology and Zoology · Cited by 135
Mizuno, Y., Suzuki, K., & Ohta, S. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90056-s · Cited by 130
Chen, R., Saunders, P. A., Wei, H., Li, Z., Seth, P. K., & Chuang, D. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09654.1999 · Cited by 122
Rossiter, J. P., Riopelle, R. J., & Bisby, M. A. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0044 · Cited by 107
DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?
Kingsbury, A. E., MARSDEN, C. D., & Foster, O. J. F. (1998) · Movement Disorders · doi:10.1002/mds.870130604 · Cited by 97
The soluble form of Fas molecule is elevated in parkinsonian brain tissues
Mogi, M., Harada, M., Kondo, T., Mizuno, Y., Narabayashi, H., Riederer, P. F., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13257-2 · Cited by 97
Cell death and apoptosis regulating proteins in Parkinson's disease - a cautionary note
Wüllner, U., Kornhuber, J., Weller, M., Schulz, J. B., Löschmann, P.-A., Riederer, P. F., & Klockgether, T. (1999) · Acta Neuropathologica · doi:10.1007/s004010051005 · Cited by 96
Endonuclease activities, chromatin structure, and DNA degradation in apoptosis
Walker, P. R., & Sikorska, M. (1994) · Biochemistry and Cell Biology · doi:10.1139/o94-081 · Cited by 91
Darżynkiewicz, Z., & Traganos, F. (1998) · Advances in biochemical engineering, biotechnology · doi:10.1007/bfb0102305 · Cited by 88
Ishitani, R., Sunaga, K., Tanaka, M., Aishita, H., & Chuang, D. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.4.542 · Cited by 72
Mitochondrial DNA and Parkinson's disease
Monte, D. A. D. (1991) · Neurology · doi:10.1212/wnl.41.5_suppl_2.38 · Cited by 68
Biochemical properties of purified human terminal deoxynucleotidyltransferase.
Deibel, M. R., & Colemán, M. S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85653-3 · Cited by 67
Effect of Postmortem Interval on In Situ End-Labeling of DNA Oligonucleosomes
Petito, C. K., & Roberts, B. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199511000-00002 · Cited by 56
Human mitochondrial complex I dysfunction
Cooper, J. A. D., Mann, V. M., Krige, D., & Schapira, A. H. V. (1992) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(05)80019-2 · Cited by 41
Nagata, S. (1999) · Nature Cell Biology · doi:10.1038/14094 · Cited by 35
Cited by
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Degterev, A., Boyce, M., & Yuan, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207107 · Cited by 1,107
Metadata
- Authors
- Tatton, N. A.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2000-11
- Volume
- 166
- Issue
- 1
- Pages
- 29-43
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W1965575645
- Cited by
- 411
- References
- 64
- FWCI
- 15.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.